Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIRAVA: Five-year boostability after single-visit single-dose intramuscular rabies pre-exposure prophylaxis
2023-510480-35-00Phase 4Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2024
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Rabies vaccine in rabies, sponsored by Leiden University Medical Center. Planned start Sep 2024; status: authorised.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on 2023-510480-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510480-35-00.